XIST and non-small cell lung carcinoma: Indeed, XIST suppression decreases cell growth and invasion and induces apoptosis in non-small-cell lung carcinoma (NSCLC) through the inhibition of miR-186-5p [83], while it promotes the progression of human hepatocellular carcinoma through the repression of the PTEN suppressor gene.